New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer

Dedifferentiated thyroid cancer (DeTC) derived from follicular epithelium is often incurable because it does not respond to radioiodine, radiotherapy, or chemotherapy. In cases, RET/PTC rearrangements are found in 30%–40%, RAS mutations in about 10%, and BRAF mutations in around 40%–50%, with no ove...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Antonelli, Alessandro, Ferri, Clodoveo, Ferrari, Silvia Martina, Sebastiani, Marco, Colaci, Michele, Ruffilli, Ilaria, Fallahi, Poupak
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2010
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2902220/
https://ncbi.nlm.nih.gov/pubmed/20628483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/921682
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars